Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $98.74 ($753K) on 2016-08-24, disclosed to the SEC on 2016-08-26.
Scheduled sale ($753k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.73 | 1,100 | $106K | 14.1% |
| 2 | $98.74 | 1,000 | $99K | 13.1% |
| 3 | $99.50 | 100 | $10K | 1.3% |
| 4 | $100.02 | 100 | $10K | 1.3% |
| 5 | $101.21 | 1,500 | $152K | 20.1% |
| 6 | $101.60 | 900 |
| $91K |
| 12.1% |
| 7 | $101.83 | 2,800 | $285K | 37.8% |
| Total | $100.46 avg | 7,500 | $753K | 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |